2011
DOI: 10.7251/bii1102021r
|View full text |Cite
|
Sign up to set email alerts
|

Uticaj korekcije anemije bolesnika sa hroničnom bubrežnom insuficijencijom na kardiovaskularni sistem

Abstract: Kratak sadržajUvod. Anemija je česta komplikacija hronične bubrežne insuficijencije, a njen glavni uzrok je nedovoljno stvaranje eritropoetina. Anemija predstavlja značajan faktor rizika za nastanak kardiovaskularnih bolesti. Cilj rada je bio da se ispita oporavak anemije tokom primjene humanog rekombinovanog eritropoetina kod bolesnika sa hroničnom bubrežnom insuficijencijom u predijaliznom periodu i uticaj korekcije anemije na kardiovaskularne promjene.Metode. U prospektivnoj studiji praćeno je 20 bolesnika … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 23 publications
0
1
0
Order By: Relevance
“…The aim of this work was to show the role of Erythropoietin to the patients on hemodialysis. By hemodialysis provides better life quality of these patients [9].…”
Section: Article Info Abstractmentioning
confidence: 99%
“…The aim of this work was to show the role of Erythropoietin to the patients on hemodialysis. By hemodialysis provides better life quality of these patients [9].…”
Section: Article Info Abstractmentioning
confidence: 99%